J. Grimshaw and I. Russell, Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations, The Lancet, vol.342, issue.8883, pp.342-1317, 1993.
DOI : 10.1016/0140-6736(93)92244-N

K. Kulkarni, G. Castle, R. Gregory, A. Holmes, C. Leontos et al., Nutrition Practice Guidelines for Type 1 Diabetes Mellitus positively affect dietitian practices and patient outcomes. The Diabetes Care and Education Dietetic Practice Group, Journal of the American Dietetic Association, issue.1, pp.62-70, 1998.

D. Debnath, N. Dielehner, and K. Gunning, Guidelines, compliance, and effectiveness: a 12 months' audit in an acute district general healthcare trust on the two week rule for suspected colorectal cancer, Postgraduate Medical Journal, vol.78, issue.926, pp.748-51, 2002.
DOI : 10.1136/pmj.78.926.748

N. Hebert-croteau, J. Brisson, J. Latreille, M. Rivard, N. Abdelaziz et al., Compliance With Consensus Recommendations for Systemic Therapy Is Associated With Improved Survival of Women With Node-Negative Breast Cancer, Journal of Clinical Oncology, vol.22, issue.18, pp.22-3685, 2004.
DOI : 10.1200/JCO.2004.07.018

S. Vikman, K. Airaksinen, I. Tierala, K. Peuhkurinen, K. Majamaa-voltti et al., Improved adherence to practice guidelines yields better outcome in high-risk patients with acute coronary syndrome without ST elevation: findings from nationwide FINACS studies, Journal of Internal Medicine, vol.36, issue.4, pp.316-339, 2004.
DOI : 10.1001/archinte.160.12.1775

R. Nieuwlaat, S. Olsson, G. Lip, A. Camm, G. Breithardt et al., Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation, American Heart Journal, vol.153, issue.6, pp.1006-1018, 2007.
DOI : 10.1016/j.ahj.2007.03.008

A. Rogers, V. Ramanath, M. Grzybowski, A. Riba, S. Jani et al., The association between guideline-based treatment instructions at the point of discharge and lower 1-year mortality in Medicare patients after acute myocardial infarction: The American College of Cardiology's Guidelines Applied in Practice (GAP) initiative in Michigan, American Heart Journal, vol.154, issue.3
DOI : 10.1016/j.ahj.2007.05.003

J. Kosecoff, D. Kanouse, W. Rogers, L. Mccloskey, C. Winslow et al., Effects of the National Institutes of Health Consensus Development Program on physician practice, Jama, vol.20, issue.19, pp.258-2708, 1987.

M. Cabana, C. Rand, N. Powe, A. Wu, M. Wilson et al., Why don t physicians follow clinical practice guidelines? A framework for improvement ', Jama, vol.20, issue.15, pp.282-1458, 1999.

S. Tunis, R. Hayward, M. Wilson, H. Rubin, E. Bass et al., Internists attitudes about clinical practice guidelines ' . Annals of internal medicine, pp.120-956, 1994.

K. Stange, R. Kelly, J. Chao, S. Zyzanski, J. Shank et al., Physician agreement with US Preventive Services Task Force recommendations . The Journal of family practice, pp.409-425, 1992.

R. Grilli and J. Lomas, Evaluating the Message: The Relationship Between Compliance Rate and the Subject of a Practice Guideline, Medical Care, vol.32, issue.3, pp.202-215, 1994.
DOI : 10.1097/00005650-199403000-00002

P. Durieux, P. Ravaud, P. Dosquet, and A. Durocher, Effectiveness of clinical guideline implementation strategies: systematic review of systematic reviews, Gastroenterol Clin Biol, issue.11, pp.1018-1043, 2000.

F. Saillour-glenisson and P. Michel, Individual and collective facilitators of and barriers to the use of clinical practice guidelines by physicians: a literature review . Revue d' epidemiologie et de sante publique, Feb, vol.51, issue.1, pp.65-80, 2003.

O. Dell and '. Jr, How is it best to treat early rheumatoid arthritis patients? . Best practice & research, pp.125-162, 2001.

M. Quinn, P. Conaghan, and P. Emery, The therapeutic approach of early intervention for rheumatoid arthritis: what is the evidence?, Rheumatology, vol.40, issue.11, pp.1211-1231, 2001.
DOI : 10.1093/rheumatology/40.11.1211

S. Verstappen, J. Jacobs, J. Bijlsma, A. Heurkens, C. Van-booma-frankfort et al., Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year . Arthritis and rheumatism, pp.1797-807, 2003.

V. Nell, K. Machold, G. Eberl, T. Stamm, M. Uffmann et al., Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis, Rheumatology, vol.43, issue.7, pp.906-920, 2004.
DOI : 10.1093/rheumatology/keh199

H. Keen and P. Emery, How should we manage early rheumatoid arthritis? From imaging to intervention . Current opinion in rheumatology, pp.280-285, 2005.

M. Weinblatt, Rheumatoid arthritis: treat now, not later ! . Annals of internal medicine, pp.124-773, 1996.

P. Emery, F. Breedveld, M. Dougados, J. Kalden, M. Schiff et al., Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide, Annals of the Rheumatic Diseases, vol.61, issue.4, pp.290-297, 2002.
DOI : 10.1136/ard.61.4.290

T. Kennedy, C. Mccabe, G. Struthers, H. Sinclair, K. Chakravaty et al., BSR guidelines on standards of care for persons with rheumatoid arthritis, Rheumatology, vol.44, issue.4, pp.553-559, 2005.
DOI : 10.1093/rheumatology/keh554

B. Combe, The French early arthritis registry Clinical and experimental rheumatology, pp.123-131, 2003.

B. Combe, J. Benessiano, F. Berenbaum, A. Cantagrel, J. Daures et al., The ESPOIR cohort: A ten-year follow-up of early arthritis in France Methodology and baseline characteristics of the 813 included patients, Joint Bone Spine, 2007.

F. Arnett, S. Edworthy, D. Bloch, D. Mcshane, J. Fries et al., The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis & Rheumatism, vol.143, issue.3, pp.315-339, 1988.
DOI : 10.1002/art.1780310302

L. Denoeud, B. Mazieres, C. Payen-champenois, and P. Ravaud, First line treatment of knee osteoarthritis in outpatients in France: adherence to the EULAR 2000 recommendations and factors influencing adherence, Annals of the Rheumatic Diseases, vol.64, issue.1, pp.70-74, 2005.
DOI : 10.1136/ard.2003.015263

M. Irwin, K. Bainey, and M. Senaratne, Evaluation of the Appropriateness of Pacemaker Mode Selection in Bradycardia Pacing:, Pacing and Clinical Electrophysiology, vol.38, issue.12, pp.2301-2308, 2003.
DOI : 10.1111/j.1540-8159.2003.00363.x

R. Perlis, Use of treatment guidelines in clinical decision making in bipolar disorder: a pilot survey of clinicians . Current medical research and opinion, pp.467-75, 2007.

T. Kvien, H. Lie, E. Kaufmann, C. Mikkelsen, K. Nordvag et al., A Norwegian DMARD register: prescriptions of DMARDs and biological agents to patients with inflammatory rheumatic diseases, Clinical and experimental rheumatology, issue.5, pp.188-94, 2005.

M. Maravic, C. Berge, J. Daures, and M. Boissier, Survey of practices regarding management of early rheumatoid arthritis by rheumatologists in France, Clinical and experimental rheumatology, issue.3, pp.319-346, 2004.

D. Aletaha and J. Smolen, The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses, Rheumatology, issue.12, pp.1367-74, 2002.

P. Jobanputra, J. Wilson, K. Douglas, and A. Burls, A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis, Rheumatology, vol.43, issue.2
DOI : 10.1093/rheumatology/keh003

T. Sokka and P. T. , Contemporary disease modifying antirheumatic drugs (DMARD) in patients with recent onset rheumatoid arthritis in a US private practice: methotrexate as the anchor drug in 90 and new DMARD in 30 of patients % %, The Journal of rheumatology, issue.12, pp.2521-2525, 2002.

V. Chan and S. Tett, Changes in use of disease-modifying anti-rheumatic drugs in Australia over the period, Pharmacoepidemiology and drug safety, issue.7, pp.462-470, 2006.

H. Van-dongen, J. Van-aken, L. Lard, K. Visser, H. Ronday et al., Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: A double-blind, randomized, placebo-controlled trial, Arthritis & Rheumatism, vol.56, issue.5, pp.1424-1456, 2007.
DOI : 10.1002/art.22525

L. Lard, H. Visser, I. Speyer, I. Vander-horst-bruinsma, A. Zwinderman et al., Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies, The American Journal of Medicine, vol.111, issue.6, pp.111-446, 2001.
DOI : 10.1016/S0002-9343(01)00872-5

J. Van-aken, L. Lard, S. Le-cessie, J. Hazes, F. Breedveld et al., Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.63, issue.3, pp.274-283, 2004.
DOI : 10.1136/ard.2003.010298